Skip to main content
SpringerLink
Log in

Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stopeck AT, Fizazi K, Body JJ et al (2016) Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer 24:447–455

    Article  PubMed  Google Scholar 

  2. Fizazi K, Carducci M, Smith M et al (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377:813–822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Stopeck AT, Lipton A, Body JJ et al (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28:5132–5139

    Article  CAS  PubMed  Google Scholar 

  4. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (2015) European Medicines Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002304.jsp&mid=WC0b01ac058004d5c1. Accessed 24 Feb 2016

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Avenue du Général Koenig, 51100, Reims, France

    Paul de Boissieu & Thierry Trenque

  2. Faculty of Medicine, University of Reims Champagne-Ardenne, EA3797, Reims, France

    Paul de Boissieu & Thierry Trenque

Authors
  1. Paul de Boissieu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thierry Trenque
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul de Boissieu.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Funding

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Boissieu, P., Trenque, T. Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab. Support Care Cancer 25, 351–352 (2017). https://doi.org/10.1007/s00520-016-3238-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3238-7

Keywords

Search

Navigation